Glycom A/S
5 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Feb 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 11 to 27, 2026 · next Dec 11
- 2 fees due Jan 11 to 30, 2027 · next Jan 11
- 2 fees due Mar 17 to 26, 2027 · next Mar 17
- 1 fee due Apr 1, 2027The maintenance fee for Mutated sialidases (US 10,428,318) comes due Apr 1, 2027. Unpaid by Oct 1, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Composition and method for treating acute respiratory tract infections (US 10,471,084) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
- 2 fees due Jun 5 to 10, 2027 · next Jun 5
- 3 fees due Aug 6 to 13, 2027 · next Aug 6
- 4 fees due Sep 5 to 26, 2027 · next Sep 5
Recent changes
- 1 term has ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,993,740 | Method for Preparation of the Tetrasaccharide Lacto-N-Neotetraose (LNNT) Containing N-Acetyllactosamine In force · High confidence | In force | High confidence | |
| US 8,889,637 | Polymorphs of 2′-O-fucosyllactose and producing thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,927,698 | Novel Method for the Synthesis of a Trisaccharide In force · Medium confidence | In force | Medium confidence | |
| US 9,963,729 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,382,564 | Diversification of human milk oligosaccharides (HMOs) or precursors thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,896,470 | Enhancing the stability and purity and increasing the bioavailability of human milk oligosaccharides or precursors or blends thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,834,574 | Crystalline 3-O-fucosyllactose In force · From the USPTO record | In force | From the USPTO record | |
| US 9,815,862 | Polymorphs of LNnT In force · From the USPTO record | In force | From the USPTO record | |
| US 9,902,984 | Fermentative production of oligosaccharides In force · From the USPTO record | In force | From the USPTO record | |
| US 10,364,449 | Fermentative production of oligosaccharides In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 73: 5 patents in force now held by others · 25 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
10 pending · 2 abandoned · 41 no status recorded